PHYSIDIA’s Post

Cardiac Sarcoidosis (CS) is a rare form of sarcoidosis in which clusters of white blood cells, called granulomas, form in the tissue of the heart. Due to its high mortality rate, early detection and prompt initiation of treatment are critical. Note: Most patients respond to treatments favorably when treated appropriately and early. Learn more: https://loom.ly/hpq0iQA #cardiacsarc #cardiacsarcoidosis #sarcoidosis

If you see severe COPD/emphysema patients, this webinar is for you. Presented by WABIP, pulmonologist Dr. ali musani will discuss Bronchoscopic Lung Volume Reduction with Endobronchial Valves as a standard of care treatment option for patients with severe COPD/emphysema. Register for this interactive webinar here: https://bit.ly/3LNEzjw   #WABIP #EndobronchialValves #Pulmonology 

Pulmonary Hypertension (PH) presents symptoms that often overlap with other lung and cardiac conditions. It is vital to distinguish PH from these look-alikes to avoid misdiagnosis and unnecessary treatments. Your expertise can make all the difference. Discover more about PH to enhance your diagnostic accuracy and patient care: https://ow.ly/m9FU50Q5aVi Together, we can improve outcomes and transform lives. 💜 #PHAwareness #HealthcareProfessionals #EarlyDiagnosisMatters #DoctorsCanada #PulmonaryDiseases

It's World Lung Day and there is hope for severe #COPD/#emphysema patients. The Zephyr Endobronchial Valve is clinically proven to help severe COPD/emphysema patients experience improved lung function, exercise capacity and quality of life. Explore the data: https://bit.ly/3DLnlQE See important safety information: https://bit.ly/3dxvPQy #Bronchology #Pulmonology #WorldLungDay #LungDisease

Thank you for your support in sharing the Pulmonary Hypertension Global Patient Survey #PHGPS! As we approach the end of phase one, with 3,400+ responses, we kindly ask for your help in sharing the survey one last time, no matter where in the world you are: pvri.link/gps #PatientCare #PatientSurvey #PulmonaryHypertension

Lung volume reduction (LVR) is a clinically proven and recommended therapy for reducing breathlessness in advanced COPD. Changes in treatment mean that minimally invasive options such as endobronchial valves, are now available, but the majority of eligible patients are not referred. Gain a deeper understanding of the assessment and treatment with endobronchial valves for LVR via this on-demand webinar ➡️ https://bit.ly/3WZ7nMb #COPD #emphysema #Pulmonx #ZephyrValves #DigitalLearning This is a non-Pulmonx link. Webinar sponsored by Pulmonx Corporation. Results may vary.

Check out the NACE On-Demand Course: PAH Targets: Patients, Receptors, and Outcomes! This CME webcast addresses the critical challenges in diagnosing and treating pulmonary arterial hypertension (PAH). Explore the 2022 ESC/ERS guidelines for a simplified approach to early identification and management. Gain insights into recognizing drug-induced PAH, screening for right heart remodeling, and employing comprehensive risk stratification. Learn how to select appropriate initial and transition therapies based on patient risk, ensuring optimal outcomes for this complex and often underdiagnosed condition. Click here to start the course: https://bit.ly/3RGi03b #CME #Webcast #OnDemand #NACE

Familiarize yourself with pulmonary hypertension and heart failure management strategies in part 2️⃣ of our interactive hemodynamics series. Join Dr. Aman Shah and Beth Davidson, DNP to learn more about how our CardioMEMS HF System can improve outcomes for your Class II-III heart failure patients: https://bit.ly/3SCkLDp US Safety Info: https://bit.ly/3Uik1Vc #MedicalEducation #RemoteMonitoring #HeartFailure

Every wound is personal - so why not bring a personal approach to wound healing? With 3C Patch, you're able to treat chronic diabetic wounds with only the patient's blood, which provides a highly concentrated amount of the patient's own leukocytes, platelets, and fibrin directly to the wound. Click here to learn more about how 3C Patch can help patient outcomes: https://lnkd.in/gEBzmrtv #diabetes #diabetesawareness #treatment #diabetestreatment

Learn more about the Air Plethysmography (APG) test and how it can benefit patients in diagnosing venous disease and assessing lower limb hemodynamics. The APG test utilises a pressure cuff as a sensor, providing valuable insights into blood volume changes at the measuring site. By performing the APG test, healthcare professionals can better understand conditions such as chronic venous obstruction, venous reflux, and venous hypertension, guiding treatment decisions for patients. Despite the simplicity and popularity of PPG sensors, APG remains a gold standard for venous testing in many cases. With high-quality inflatable cuffs available in various sizes, conducting the APG test using devices like the Falcon is fast and straightforward. The Falcon's dedicated APG protocol allows for bilateral testing on multiple sites, offering detailed insights into venous hemodynamics. By utilising the Falcon's Sweep time and Scale options, healthcare providers can zoom in or out of waveforms to identify trend changes in the APG signal accurately. Consider incorporating the APG test into your diagnostic toolkit for comprehensive assessment of venous conditions and optimising patient care. Read more: https://lnkd.in/g-4Ycd_Q #Medicine #MedTech #BloodVolume #Medical #Healthcare